SeattleNTC Revenue and Competitors
Estimated Revenue & Valuation
- SeattleNTC's estimated annual revenue is currently $10.8M per year.
- SeattleNTC's estimated revenue per employee is $216,000
Employee Data
- SeattleNTC has 50 Employees.
- SeattleNTC grew their employee count by 16% last year.
SeattleNTC's People
Name | Title | Email/Phone |
---|---|---|
1 | Medical Director | Reveal Email/Phone |
2 | Medical Director, Bellingham Clinic | Reveal Email/Phone |
3 | Managing Partner, Director Child & Adolescent Psychiatry | Reveal Email/Phone |
4 | Partner, Director Neuropsychiatry and Research | Reveal Email/Phone |
5 | Operations Manager | Reveal Email/Phone |
6 | Clinical Manager | Reveal Email/Phone |
7 | Patient Care Coordinator | Reveal Email/Phone |
8 | Patient Care Coordinator | Reveal Email/Phone |
9 | TMS Clinician | Reveal Email/Phone |
10 | TMS/Esketamine Technician | Reveal Email/Phone |
SeattleNTC Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8M | 37 | 6% | N/A | N/A |
#2 | $8.6M | 40 | 8% | N/A | N/A |
#3 | $7.3M | 34 | 10% | N/A | N/A |
#4 | $10.8M | 50 | 16% | N/A | N/A |
#5 | $74.3M | 250 | 3% | N/A | N/A |
#6 | $70.4M | 237 | 6% | N/A | N/A |
#7 | $24.3M | 90 | -7% | N/A | N/A |
#8 | $44M | 148 | 12% | N/A | N/A |
#9 | $30.8M | 114 | 6% | N/A | N/A |
#10 | $7.8M | 36 | -8% | N/A | N/A |
What Is SeattleNTC?
Seattle Neuropsychiatric Treatment Center (SeattleNTC) specializes in Transcranial Magnetic Stimulation (TMS), Electroconvulsive Therapy (ECT), esketamine, and other cutting-edge treatments for depression and difficult to treat neuropsychiatric disorders. We have locations in Seattle, Bellevue, and Tacoma, and we also offer telehealth appointments. SeattleNTC's founder, Kenneth Melman MD, has been an active member of the Seattle medical and psychiatric community for more than 30 years. SeattleNTC is the oldest TMS clinic in the region and the only clinic to offer all three treatments for severe depression: TMS, ECT, and esketamine.
keywords:N/AN/A
Total Funding
50
Number of Employees
$10.8M
Revenue (est)
16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6M | 50 | 0% | N/A |
#2 | $8.8M | 50 | 28% | N/A |
#3 | $5.8M | 50 | N/A | N/A |
#4 | $8.6M | 50 | -12% | N/A |
#5 | $7.6M | 50 | 6% | N/A |